Search research articles
Contact Us
Filters
Showing results (291-300 of 372) with videos related to
Page
of 38
Sort By:
Leukemia & Lymphoma
|
December 17, 2024
CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial
Caspian Oliai, Sunmin Park, Lloyd E Damon, et al.
Journal of the American Society for Mass Spectrometry
|
December 8, 2016
Autopiquer - a Robust and Reliable Peak Detection Algorithm for Mass Spectrometry
David P A Kilgour, Sam Hughes, Samantha L Kilgour, et al.
Annals of Internal Medicine
|
April 20, 2011
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications
Veronica Yank, C Vaughan Tuohy, Aaron C Logan, et al.
Accident; Analysis and Prevention
|
April 13, 2010
Simulator sickness during driving simulation studies
Johnell O Brooks, Richard R Goodenough, Matthew C Crisler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 22, 2016
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation
Matthew P Mulé, Gabriel N Mannis, Brent L Wood, et al.
Leukemia
|
February 20, 2013
Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia
A C Logan, B Zhang, B Narasimhan, et al.
Trends in Cell Biology
|
August 25, 2012
Mitochondrial 'flashes': a radical concept repHined
Markus Schwarzländer, Michael P Murphy, Michael R Duchen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 14, 2014
Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia
Behzad Kharabi Masouleh, Huimin Geng, Christian Hurtz, et al.
Analytical Chemistry
|
August 2, 2014
Mass spectrometry imaging of cassette-dosed drugs for higher throughput pharmacokinetic and biodistribution analysis
John G Swales, James W Tucker, Nicole Strittmatter, et al.
Leukemia Research
|
June 6, 2025
A phase 1 trial of ibrutinib and azacitidine for higher risk myelodysplastic syndromes (University of California Hematologic Malignancies Consortium Study 1503)
Brian A Jonas, Samantha C Fisch, Peter T Curtin, et al.
Page
of 38
Search research articles
Search
Showing results (291-300 of 372) with videos related to
Sort By:
Page
of 38
Leukemia & Lymphoma
|
December 17, 2024
CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial
Caspian Oliai, Sunmin Park, Lloyd E Damon, et al.
Journal of the American Society for Mass Spectrometry
|
December 8, 2016
Autopiquer - a Robust and Reliable Peak Detection Algorithm for Mass Spectrometry
David P A Kilgour, Sam Hughes, Samantha L Kilgour, et al.
Annals of Internal Medicine
|
April 20, 2011
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications
Veronica Yank, C Vaughan Tuohy, Aaron C Logan, et al.
Accident; Analysis and Prevention
|
April 13, 2010
Simulator sickness during driving simulation studies
Johnell O Brooks, Richard R Goodenough, Matthew C Crisler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 22, 2016
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation
Matthew P Mulé, Gabriel N Mannis, Brent L Wood, et al.
Leukemia
|
February 20, 2013
Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia
A C Logan, B Zhang, B Narasimhan, et al.
Trends in Cell Biology
|
August 25, 2012
Mitochondrial 'flashes': a radical concept repHined
Markus Schwarzländer, Michael P Murphy, Michael R Duchen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 14, 2014
Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia
Behzad Kharabi Masouleh, Huimin Geng, Christian Hurtz, et al.
Analytical Chemistry
|
August 2, 2014
Mass spectrometry imaging of cassette-dosed drugs for higher throughput pharmacokinetic and biodistribution analysis
John G Swales, James W Tucker, Nicole Strittmatter, et al.
Leukemia Research
|
June 6, 2025
A phase 1 trial of ibrutinib and azacitidine for higher risk myelodysplastic syndromes (University of California Hematologic Malignancies Consortium Study 1503)
Brian A Jonas, Samantha C Fisch, Peter T Curtin, et al.
Page
of 38